Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients. Clement J, Duffau P, Constans J, Schaeverbeke T, et al. J Rheumatol 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.

Read + Share

Amedeo Smart

Independent Medical Education

Clement J, Duffau P, Constans J, Schaeverbeke T, et al. Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients. J Rheumatol 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.
PMID: 33589561